Joke Collection Website - Blessing messages - ANOVA's products and services

ANOVA's products and services

Facing the diverse health needs of the public and the research needs of researchers, the company organizes excellent scientific research forces to develop and launch brand-new products and services. Through non-invasive prenatal DNA testing, the risk rate of fetal chromosome aneuploidy was analyzed to avoid the low accuracy of traditional Down's screening and the risk of abortion and intrauterine infection caused by amniocentesis. At present, 2 1- trisomy syndrome (Down's syndrome), 18- trisomy syndrome (Edward's syndrome) and 13- trisomy syndrome (Patau's syndrome) with high incidence are all within the detection range.

Its technical advantages are as follows:

1. Non-invasive sampling, safe and secure: Only 5ml of pregnant women's peripheral blood can be taken for non-invasive prenatal DNA testing, and there is no need for invasive sampling such as amniocentesis, villus sampling or umbilical vein blood sampling, thus avoiding the risk of intrauterine infection and abortion.

2. high-throughput sequencing, the result is more accurate: The non-invasive prenatal DNA detection is based on the new generation of high-throughput sequencing and information analysis technology, and the analysis result is more accurate, which greatly reduces the disadvantages of high missed detection rate and false positive rate of traditional Down's screening method.

3. Early detection of pregnancy, early knowledge of health: the detection time of non-invasive prenatal DNA detection technology can start from 12 weeks of pregnancy and last until 24 weeks of pregnancy. Compared with amniocentesis sampling at 16~2 1 week, it can start earlier and last longer. Provide efficient, high-quality and professional human genome sequencing and bioinformatics analysis solutions for researchers, help researchers to conduct in-depth research on various human diseases (single-gene diseases, complex diseases and cancers), comprehensively analyze the relationship between gene variation and diseases, and accelerate the clinical application transformation of basic medical research on the basis of fully understanding the biological mechanism leading to the occurrence and development of diseases.